Skip to content

The efficacy of Recove® topical ointment in pain alleviation, blister suppression, microbial control and wound healing in burn lesions

Evaluation of Recove® topical ointment efficacy in pain alleviation, blister suppression, microbial control and wound healing in burn lesions: A randomized clinical trial study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201606148177N15
Enrollment
60
Registered
2016-06-29
Start date
2016-06-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn wound. Burns and corrosions

Interventions

Intervention 1: Intervention group: In the study group, after washing the wound with normal saline, a relatively thick layer of Recove ointment to be used and dressing is doing with sterile gauze. Pre
Treatment - Drugs
Intervention group: In the study group, after washing the wound with normal saline, a relatively thick layer of Recove ointment to be used and dressing is doing with sterile gauze. Prescription of ora
Control group: Patients enrolled in the control group are treated according to routine care of emergency room, including washing with normal saline, and dressing with topical Nitrofurazon cream 0.2% a

Sponsors

Tosan darou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients between 12-70 years old with burn injury including grade 1 and 2 that have burned during 6 hours before admission. Exclusion criteria: Dissatisfaction to enter the study; more than 10% TBSA burn; Need to be hospitalized; Burn wounds in head, face or genitalia; Electrical and Chemical Burns; Need to intravenous analgesic; Immunodeficiency; Diabetics; using Corticosteroid; uncontrolled hypertension; Withdrawing from the study; burn wound infection proved through clinical examination; Technical or human error in the process of treatment.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: First hour after dressing. Method of measurement: Numerical Scale.;Blister. Timepoint: first day. Method of measurement: Observation.;Microbial control. Timepoint: The 4th day. Method of measurement: Wound cultures in EMB& Blood Agar.;Wound healing. Timepoint: First day, 4th day, 10th day. Method of measurement: Photo and observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParviz Namazi

Iran University of Medical Science

namaziparviz@gmail.com+98 21 8877 0046

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026